@article {1388,
	title = {Administration of efavirenz (600 mg/day) with rifampicin results in highly variable levels but excellent clinical outcomes in patients treated for tuberculosis and HIV.},
	journal = {The Journal of antimicrobial chemotherapy},
	volume = {58},
	year = {2006},
	month = {2006 Dec},
	pages = {1299-302},
	abstract = {Pharmacokinetic interactions between rifampicin and antiretroviral therapy (ART), including efavirenz, are problematic and need to be better defined to determine proper dose and to be correlated with short-term and long-term clinical outcomes.},
	keywords = {Adult, Anti-HIV Agents, Antibiotics, Antitubercular, Benzoxazines, CD4 Lymphocyte Count, Chromatography, High Pressure Liquid, Didanosine, Drug Therapy, Combination, Female, HIV Infections, Humans, Lamivudine, Longitudinal Studies, Male, Oxazines, Rifampin, Treatment Outcome, Tuberculosis, Pulmonary, Viral Load},
	issn = {0305-7453},
	doi = {10.3109/00952990.2011.568081},
	author = {Friedland, Gerald and Khoo, Saye and Jack, Christopher and Lalloo, Umesh}
}
